SnapShot: p38 MAPK Substrates
The ability of p38a mitogen-activated protein kinase (MAPK14) to phosphorylate many downstream substrates allows this pathway to regulate a wide variety of cellular processes. Thus, based on the nature of the substrates phosphorylated by p38a, cells can decide whether to live or die or whether they should engage into specific programs of growth, proliferation, or differentiation. All p38a-mediated phosphorylations have been reported to occur on Ser or Thr residues, which are usually followed by a Pro residue. Consistent with this notion, about 85% of the p38a phosphorylation sites described so far correspond to Ser-Pro or Thr-Pro motifs (see Table S1 available online). Intriguingly, Ser-Pro/Thr-Pro sites are extremely common and thus most human proteins could be potential p38a substrates. Therefore, it is clear that additional substrate recognition mechanisms should be involved to ensure signaling fidelity.
A key aspect of kinase-substrate recognition is based on the interaction of the kinase catalytic cleft with the target phosphor-acceptor residue. However, some substrates also contain specific binding regions referred to as docking sites, which are not related to the phosphorylation sites but play key roles in efficient substrate phosphorylation. The best-characterized MAPK docking site is the D domain, which consists of two or more basic residues and a stretch of hydrophobic residues with a short linker in between. Nevertheless, it is important to note that many p38a substrates do not seem to contain docking domains. In these cases, it is likely that substrate selection depends on other determinants such as availability, concentration, and subcellular localization. There is evidence that p38a can be detected in both the cytoplasm and the nucleus, suggesting the existence of different pools of p38a that could be specifically targeted by particular stimuli. The availability of binding partners may also impinge on p38a subcellular localization. Another factor that is likely to influence substrate determination is the strength and duration of p38a activity in the cell. Altogether, the pool of substrates phosphorylated by p38a in each case will provide the cell with information required to orchestrate the adequate response.
The table, a companion to the SnapShot "p38 MAPK Signaling" in the January 31 issue of Cell, shows 66 p38a substrates that are divided into eight different groups based on biochemical function. All indicated proteins have been shown to be directly phosphorylated by p38a in vitro, using either recombinant or immunoprecipitated p38a. In most cases, residues phosphorylated by p38a have been mapped. Numbers refer to the human proteins except for the three cases indicated by (m), which are mouse proteins. n/d, not determined. We have also analyzed the published data, paying special attention to the supporting evidence of phosphorylation and functional consequences.
Many substrates have been validated in vivo using either generic or specific phospho-antibodies. "In cells" refers to the detection of the phosphorylation events in either overexpressed or endogenous proteins of mammalian cells. "Inhibitor" refers to the use of chemical compounds-mainly SB203580 or SB202190-to impair substrate phosphorylation in cells. "+" indicates that inhibitors were used at 10 mM or lower concentration; "+/-" indicates that inhibitors were used at >10 mM. "Mutation" indicates that phosphorylation sites were confirmed by mutation of the corresponding residues. Some substrates have been reported to interact with p38a based on coimmunoprecipitation (CoIP), yeast two-hybrid (Y2H), or pull-down (PD) experiments. The effects produced on the substrates by p38a phosphorylation are also indicated.
A future challenge will be to identify the set of proteins that are phosphorylated upon p38a activation in different contexts, which should help to elucidate how cells respond to multiple extracellular signals and changing environmental conditions.
